Ellis Sean
SEC Form 4 insider trading activity
Ellis Sean has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Aug 7, 2026.
On the most recent filing, Ellis Sean is listed as Director at Entera Bio Ltd. Inside the rolling window, Ellis Sean reported 2 open-market purchases totaling $35K in ENTX and no open-market sales. The largest disclosed transaction in the window is a purchase of 18,000 ENTX shares on Feb 9, 2026, worth $22K.
Companies traded
Other insiders at ENTX
Insider Buying
$35K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ellis Sean made?
Ellis Sean has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Ellis Sean trade?
Ellis Sean has filed SEC Form 4 disclosures for 1 company, including ENTX.
When was Ellis Sean's most recent SEC Form 4 filing?
Ellis Sean's most recent SEC Form 4 filing on Tracefour is dated Aug 7, 2026.
What is Ellis Sean's total buy and sell value in the current window?
Inside the rolling retention window, Ellis Sean bought $35K and sold $0 based on SEC Form 4 filings.
What was Ellis Sean's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 18,000 ENTX shares on 2026-02-09, worth $22K, per SEC Form 4 filings.